Eve M. Taylor, PhD

Eve M. Taylor, PhD has extensive experience in clinical development and consulting roles in the biopharmaceutical industry. Eve is currently working at Engrail Therapeutics, where they hold the position of Senior Vice President, Clinical Development since January 2023. Prior to this, they served as the Vice President, Clinical Development at Engrail Therapeutics from June 2020 to January 2023.

Before joining Engrail Therapeutics, Eve worked at Intra-Cellular Therapies as a Senior Director, Clinical Development from March 2017 to June 2020. Eve also held positions at Cytori Therapeutics, where they worked as a Senior Director and later as a Director of Clinical Development from April 2013 to October 2016.

Eve has also worked as an Independent Consultant at Taylored BioConsulting, Inc. from May 2008 to June 2013. Prior to this, they served as the Director of Clinical Development at Ceregene, Inc. from February 2007 to May 2008.

Their earlier experience includes roles at ACADIA Pharmaceuticals, Inc. as an Associate Director, Clinical Development from October 2003 to February 2007, and at Spectrum Pharmaceuticals (formerly NeoTherapeutics, Inc.) as the Director of Scientific Affairs from March 1998 to March 2003.

Eve began their career as a Postgraduate Research Neuroscientist at UC San Diego from 1995 to 1998, and prior to that, they were a Post-doctoral Fellow at the Salk Institute from 1993 to 1995.

Eve M. Taylor, PhD, obtained their Bachelor of Science degree in Physiology and Biochemistry from The University of Western Australia, where they attended from 1985 to 1988. Eve then went on to pursue a PhD in Biochemistry at King's College London, completing their doctoral studies from 1989 to 1993.